Benzion Amoyav was always drawn to science. As a high school student, he studied both chemistry and biology, and was looking forward to continuing studying science at the university level. But at the same time, he also wanted his studies to benefit society. He decided to study pharmacy, which perfectly blended his two passions.
During his undergraduate studies, Benzion conducted research in Prof. Ofra Benny’s laboratory, focused on developing a system that produces highly tunable micro- and nanoparticles for treating tumors. These “smart” particles primarily attack the tumor and release drugs in a controlled manner, resulting in better patient outcomes and less negative side effects.
After graduating, Benzion completed his internship at Hadassah, received his pharmacy license, and returned to Prof. Benny’s lab to continue with his research, eventually earning a master’s degree.
Today, as a doctoral student, Benzion is researching liver cancer and embolization (blocking solid tumors’ blood supply), a common, yet limited-efficacy, clinical practice for treating various types of tumors. He is taking a radically different approach by countering the microenvironmental conditions that are favorable to tumors. His main effort is to develop a drug-delivery device for focused therapy in combination with embolization.
By releasing the drug in a targeted fashion in close proximity to the tumor, Benzion’s research will enable doctors to reduce side effects, increase efficiency, and improve clinical outcomes.
"I believe that research education is the key for innovation and improvement, because laboratory-based discoveries can help large numbers of people. I am grateful for having the opportunity to impact other people’s lives."